000			01983 a2200577 4500
005			20250517204713.0
264		0	_c20180705
008			201807s 0 0 eng d
022			_a1932-6203
024	7		_a10.1371/journal.pone.0194329 _2doi
040			_aNLM _beng _cNLM
100	1		_aMaunoury, Franck
245	0	0	_aCost-effectiveness analysis of elbasvir-grazoprevir regimen for treating hepatitis C virus genotype 1 infection in stage 4-5 chronic kidney disease patients in France. _h[electronic resource]
260			_bPloS one _c2018
300			_ae0194329 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAmides
650	0	4	_aAntiviral Agents _xeconomics
650	0	4	_aBenzofurans _xeconomics
650	0	4	_aCarbamates
650	0	4	_aCost-Benefit Analysis _xmethods
650	0	4	_aCyclopropanes
650	0	4	_aDrug Therapy, Combination _xeconomics
650	0	4	_aFemale
650	0	4	_aFrance
650	0	4	_aGenotype
650	0	4	_aHepacivirus _xgenetics
650	0	4	_aHepatitis C, Chronic _xcomplications
650	0	4	_aHumans
650	0	4	_aImidazoles _xeconomics
650	0	4	_aKidney Failure, Chronic _xcomplications
650	0	4	_aLiver Cirrhosis _xcomplications
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aModels, Economic
650	0	4	_aQuality-Adjusted Life Years
650	0	4	_aQuinoxalines _xeconomics
650	0	4	_aRNA, Viral _xgenetics
650	0	4	_aRandomized Controlled Trials as Topic
650	0	4	_aRenal Dialysis
650	0	4	_aSulfonamides
700	1		_aClément, Aurore
700	1		_aNwankwo, Chizoba
700	1		_aLevy-Bachelot, Laurie
700	1		_aAbergel, Armand
700	1		_aDi Martino, Vincent
700	1		_aThervet, Eric
700	1		_aDurand-Zaleski, Isabelle
773	0		_tPloS one _gvol. 13 _gno. 3 _gp. e0194329
856	4	0	_uhttps://doi.org/10.1371/journal.pone.0194329 _zAvailable from publisher's website
999			_c28183563 _d28183563